New intercellular lipid mediators and their GPCRs: An update

Prostaglandins and Other Lipid Mediators

Volumn 89, Issue 3-4, 2009, Pages 53-56

  Im, Dong Soon ^a  

^a Pusan National University   (South Korea)

Author keywords

Bile acid; Fatty acid; GPCR; Lipid; Lipid mediator; Lysophospholipid

Indexed keywords

5 OXO ETE; 9 HYDROXYOCTADECADIENOIC ACID; ARACHIDNONYLETHANOLAMIDE; BILE ACID; ESTROGEN; FATTY ACID; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR 119; G PROTEIN COUPLED RECEPTOR 55; ICOSATETRAENOIC ACID; LYSOPHOSPHATIDIC ACID; LYSOPHOSPHATIDYLCHOLINE; LYSOPHOSPHOLIPID; N ARACHIDONYL GLYCINE; N OLEOYLETHANOLAMINE; N PALMITOYL GLYCINE; RESOLVIN E1; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; CELL MEMBRANE; EDITORIAL; HUMAN; INTERCELLULAR SPACE; LIPID ANALYSIS; MOLECULAR DYNAMICS; NONHUMAN;

ANIMALS; ARACHIDONIC ACIDS; BILE ACIDS AND SALTS; DRUG DISCOVERY; HUMANS; LIPIDS; LYSOPHOSPHOLIPIDS; RECEPTORS, EICOSANOID; RECEPTORS, ESTROGEN; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, LYSOPHOSPHOLIPID; SIGNAL TRANSDUCTION;

EID: 69549089928     PISSN: 10988823     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.prostaglandins.2009.01.002     Document Type: Editorial

References (112)

1. Im D.S. Discovery of new G protein-coupled receptors for lipid mediators. J Lipid Res 45 3 (2004) 410-418
2. Filardo E.J., and Thomas P. GPR30: a seven-transmembrane-spanning estrogen receptor that triggers EGF release. Trends Endocrinol Metab 16 8 (2005) 362-367
3. Maruyama T., Miyamoto Y., Nakamura T., et al. Identification of membrane-type receptor for bile acids (M-BAR). Biochem Biophys Res Commun 298 5 (2002) 714-719
4. Kawamata Y., Fujii R., Hosoya M., et al. A G protein-coupled receptor responsive to bile acids. J Biol Chem 278 11 (2003) 9435-9440
5. Prossnitz E.R., Sklar L.A., Oprea T.I., and Arterburn J.B. GPR30: a novel therapeutic target in estrogen-related disease. Trends Pharmacol Sci 29 3 (2008) 116-123
6. Rivera R., and Chun J. Biological effects of lysophospholipids. Rev Physiol Biochem Pharmacol 160 (2008) 25-46
7. McIntyre T.M., Pontsler A.V., Silva A.R., et al. Identification of an intracellular receptor for lysophosphatidic acid (LPA): LPA is a transcellular PPARγ agonist. Proc Natl Acad Sci USA 100 1 (2003) 131-136
8. Tyndall J.D., and Sandilya R. GPCR agonists and antagonists in the clinic. Med Chem 1 4 (2005) 405-421
9. Vassilatis D.K., Hohmann J.G., Zeng H., et al. The G protein-coupled receptor repertoires of human and mouse. Proc Natl Acad Sci USA 100 8 (2003) 4903-4908
10. Im D.S. Orphan G protein-coupled receptors and beyond. Jpn J Pharmacol 90 2 (2002) 101-106
11. Shimizu T. Lipid mediators in health and disease: enzymes and receptors as therapeutic targets for the regulation of immunity and inflammation. Annu Rev Pharmacol Toxicol 49 (2009) 123-150
12. Meyer zu Heringdorf D., and Jakobs K.H. Lysophospholipid receptors: signalling, pharmacology and regulation by lysophospholipid metabolism. Biochim Biophys Acta 1768 4 (2007) 923-940
13. Howlett A.C. A short guide to the nomenclature of seven-transmembrane spanning receptors for lipid mediators. Life Sci 77 14 (2005) 1522-1530
14. Kostenis E. A glance at G-protein-coupled receptors for lipid mediators: a growing receptor family with remarkably diverse ligands. Pharmacol Ther 102 3 (2004) 243-257
15. Boyce J.A. Eicosanoids in asthma, allergic inflammation, and host defense. Curr Mol Med 8 5 (2008) 335-349
16. Calder P.C. Polyunsaturated fatty acids, inflammatory processes and inflammatory bowel diseases. Mol Nutr Food Res 52 8 (2008) 885-897
17. Nixon G.F., Mathieson F.A., and Hunter I. The multi-functional role of sphingosylphosphorylcholine. Prog Lipid Res 47 1 (2008) 62-75
18. McCormick B.A. Bacterial-induced hepoxilin A3 secretion as a pro-inflammatory mediator. Febs J 274 14 (2007) 3513-3518
19. 4 receptor 2. J Exp Med 205 4 (2008) 759-766
20. Thomas C., Auwerx J., and Schoonjans K. Bile acids and the membrane bile acid receptor TGR5-connecting nutrition and metabolism. Thyroid 18 2 (2008) 167-174
21. Narumiya S., Sugimoto Y., and Ushikubi F. Prostanoid receptors: structures, properties, and functions. Physiol Rev 79 4 (1999) 1193-1226
22. Brink C., Dahlen S.E., Drazen J., et al. International Union of Pharmacology XXXVII. Nomenclature for leukotriene and lipoxin receptors. Pharmacol Rev 55 1 (2003) 195-227
23. Matsuda L.A., Lolait S.J., Brownstein M.J., Young A.C., and Bonner T.I. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346 6284 (1990) 561-564
24. Chun J., Goetzl E.J., Hla T., et al. International Union of Pharmacology XXXIV. Lysophospholipid receptor nomenclature. Pharmacol Rev 54 2 (2002) 265-269
25. Im D.S. Two ligands for a GPCR, proton vs lysolipid. Acta Pharmacol Sin 26 12 (2005) 1435-1441
26. Tomura H., Mogi C., Sato K., and Okajima F. Proton-sensing and lysolipid-sensitive G-protein-coupled receptors: a novel type of multi-functional receptors. Cell Signal 17 12 (2005) 1466-1476
27. Mogi C., Tomura H., Tobo M., et al. Sphingosylphosphorylcholine antagonizes proton-sensing ovarian cancer G-protein-coupled receptor 1 (OGR1)-mediated inositol phosphate production and cAMP accumulation. J Pharmacol Sci 99 2 (2005) 160-167
28. Wang J.Q., Kon J., Mogi C., et al. TDAG8 is a proton-sensing and psychosine-sensitive G-protein-coupled receptor. J Biol Chem 279 44 (2004) 45626-45633
29. Radu C.G., Nijagal A., McLaughlin J., Wang L., and Witte O.N. Differential proton sensitivity of related G protein-coupled receptors T cell death-associated gene 8 and G2A expressed in immune cells. Proc Natl Acad Sci USA 102 5 (2005) 1632-1637
30. Murakami N., Yokomizo T., Okuno T., and Shimizu T. G2A is a proton-sensing G-protein coupled receptor antagonized by lysophosphatidylcholine. J Biol Chem 279 41 (2004) 42484-42491
31. Peter C., Waibel M., Radu C.G., et al. Migration to apoptotic "find-me" signals is mediated via the phagocyte receptor G2A. J Biol Chem 283 9 (2008) 5296-5305
32. Zou Y., Kim C.H., Chung J.H., et al. Upregulation of endothelial adhesion molecules by lysophosphatidylcholine. Involvement of G protein-coupled receptor GPR4. Febs J 274 10 (2007) 2573-2584
33. Huang F., Mehta D., Predescu S., Kim K.S., and Lum H. A novel lysophospholipid- and pH-sensitive receptor, GPR4, in brain endothelial cells regulates monocyte transmigration. Endothelium 14 1 (2007) 25-34
34. Qiao J., Huang F., Naikawadi R.P., Kim K.S., Said T., and Lum H. Lysophosphatidylcholine impairs endothelial barrier function through the G protein-coupled receptor GPR4. Am J Physiol Lung Cell Mol Physiol 291 1 (2006) L91-101
35. Kim K.S., Ren J., Jiang Y., et al. GPR4 plays a critical role in endothelial cell function and mediates the effects of sphingosylphosphorylcholine. Faseb J 19 7 (2005) 819-821
36. Tobo M., Tomura H., Mogi C., et al. Previously postulated "ligand-independent" signaling of GPR4 is mediated through proton-sensing mechanisms. Cell Signal 19 8 (2007) 1745-1753
37. Yang L.V., Radu C.G., Roy M., et al. Vascular abnormalities in mice deficient for the G protein-coupled receptor GPR4 that functions as a pH sensor. Mol Cell Biol 27 4 (2007) 1334-1347
38. 2+ signals. Curr Biol 18 10 (2008) 781-785
39. 2 production in response to acidic pH through OGR1 in a human osteoblastic cell line. J Bone Miner Res 23 7 (2008) 1129-1139
40. Pereverzev A., Komarova S.V., Korcok J., et al. Extracellular acidification enhances osteoclast survival through an NFAT-independent, protein kinase C-dependent pathway. Bone 42 1 (2008) 150-161
41. Frick K.K., Krieger N.S., Nehrke K., and Bushinsky D.A. Metabolic acidosis increases intracellular calcium in bone cells through activation of the proton receptor OGR1. J Bone Miner Res 24 (2009) 305-313
42. 2 production and cAMP accumulation in response to acidic extracellular pH through OGR1 in human aortic smooth muscle cells. J Biol Chem 280 41 (2005) 34458-34464
43. Seuwen K., Ludwig M.G., and Wolf R.M. Receptors for protons or lipid messengers or both?. J Recept Signal Transduct Res 26 5-6 (2006) 599-610
44. Obinata H., Hattori T., Nakane S., Tatei K., and Izumi T. Identification of 9-hydroxyoctadecadienoic acid and other oxidized free fatty acids as ligands of the G protein-coupled receptor G2A. J Biol Chem 280 49 (2005) 40676-40683
45. Obinata H., and Izumi T. G2A as a receptor for oxidized free fatty acids. Prostaglandins Other Lipid Mediat 89 (2009) 66-72
46. Kabarowski J.H.S. G2A and LPC: regulatory functions in adaptive immunity. Prostaglandins Other Lipid Mediat 89 (2009) 73-81
47. Eggerickx D., Denef J.F., Labbe O., et al. Molecular cloning of an orphan G-protein-coupled receptor that constitutively activates adenylate cyclase. Biochem J 309 Pt 3 (1995) 837-843
48. Uhlenbrock K., Gassenhuber H., and Kostenis E. Sphingosine 1-phosphate is a ligand of the human GPR3, GPR6 and GPR12 family of constitutively active G protein-coupled receptors. Cell Signal 14 11 (2002) 941-953
49. Ignatov A., Lintzel J., Hermans-Borgmeyer I., et al. Role of the G-protein-coupled receptor GPR12 as high-affinity receptor for sphingosylphosphorylcholine and its expression and function in brain development. J Neurosci 23 3 (2003) 907-914
50. 2+ release by activating the sphingosine-kinase pathway. Biochem Biophys Res Commun 311 2 (2003) 329-336
51. Bresnick J.N., Skynner H.A., Chapman K.L., et al. Identification of signal transduction pathways used by orphan G protein-coupled receptors. Assay Drug Dev Technol 1 2 (2003) 239-249
52. Ledent C., Demeestere I., Blum D., et al. Premature ovarian aging in mice deficient for GPR3. Proc Natl Acad Sci USA 102 25 (2005) 8922-8926
53. 3 maintains meiotic arrest in mammalian oocytes. Science 306 5703 (2004) 1947-1950
54. Hinckley M., Vaccari S., Horner K., Chen R., and Conti M. The G-protein-coupled receptors GPR3 and GPR12 are involved in cAMP signaling and maintenance of meiotic arrest in rodent oocytes. Dev Biol 287 2 (2005) 249-261
55. Noguchi K., Ishii S., and Shimizu T. Identification of p2y9/GPR23 as a novel G protein-coupled receptor for Lysophosphatidic acid, structurally distant from the Edg family. J Biol Chem 278 (2003) 25600-25606
56. 12/13-mediated Rho activation. J Biol Chem 282 7 (2007) 4310-4317
57. 5. J Biol Chem 281 33 (2006) 23589-23597
58. Kotarsky K., Boketoft A., Bristulf J., et al. Lysophosphatidic acid binds to and activates GPR92, a G protein-coupled receptor highly expressed in gastro-intestinal lymphocytes. J Pharmacol Exp Ther 318 2 (2006) 619-628
59. Pasternack S.M., von Kugelgen I., Aboud K.A., et al. G protein-coupled receptor P2Y5 and its ligand LPA are involved in maintenance of human hair growth. Nat Genet 40 3 (2008) 329-334
60. Tabata K., Baba K., Shiraishi A., Ito M., and Fujita N. The orphan GPCR GPR87 was deorphanized and shown to be a lysophosphatidic acid receptor. Biochem Biophys Res Commun 363 3 (2007) 861-866
61. Oh da Y., Yoon J.M., Moon M.J., et al. Identification of farnesyl pyrophosphate and N-arachidonylglycine as endogenous ligands for GPR92. J Biol Chem 283 30 (2008) 21054-21064
62. 5. Prostaglandins Other Lipid Mediat 2009:88, in press.
63. Briscoe C.P., Tadayyon M., Andrews J.L., et al. The orphan G protein-coupled receptor GPR40 is activated by medium and long chain fatty acids. J Biol Chem 278 13 (2003) 11303-11311
64. Itoh Y., Kawamata Y., Harada M., et al. Free fatty acids regulate insulin secretion from pancreatic beta cells through GPR40. Nature 422 6928 (2003) 173-176
65. Brown A.J., Goldsworthy S.M., Barnes A.A., et al. The Orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. J Biol Chem 278 13 (2003) 11312-11319
66. Le Poul E., Loison C., Struyf S., et al. Functional characterization of human receptors for short chain fatty acids and their role in polymorphonuclear cells activation. J Biol Chem 278 (2003) 25481-25489
67. Nilsson N.E., Kotarsky K., Owman C., and Olde B. Identification of a free fatty acid receptor, FFA(2)R, expressed on leukocytes and activated by short-chain fatty acids. Biochem Biophys Res Commun 303 4 (2003) 1047-1052
68. Hirasawa A., Tsumaya K., Awaji T., et al. Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120. Nat Med 11 1 (2005) 90-94
69. Tsujimoto G. Fatty acids receptors (GPR40, GPR41, GPR43 and GPR120). Prostaglandins Other Lipid Mediat 2009:88, in press.
70. Niedernberg A., Tunaru S., Blaukat A., Ardati A., and Kostenis E. Sphingosine 1-phosphate and dioleoylphosphatidic acid are low affinity agonists for the orphan receptor GPR63. Cell Signal 15 4 (2003) 435-446
71. Sugo T., Tachimoto H., Chikatsu T., et al. Identification of a lysophosphatidylserine receptor on mast cells. Biochem Biophys Res Commun 341 4 (2006) 1078-1087
72. Makido K., Kitamura H., Sato Y., Okutani M., and Aoki J. Emerging lysophospholipid mediators, lysophosphatidylserine, lysophosphatidylthreonine, lysophosphatidylethanolamine, and lysophosphatidylglyreol. Prostaglandins Other Lipid Mediat (2009) 88 in press
73. Park K.S., Kim M.K., Im D.S., and Bae Y.S. Effect of lysophosphatidylglycerol on several signaling molecules in OVCAR-3 human ovarian cancer cells: involvement of pertussis toxin-sensitive G-protein coupled receptor. Biochem Pharmacol 73 5 (2007) 675-681
74. Park K.S., Lee H.Y., Lee S.Y., et al. Lysophosphatidylethanolamine stimulates chemotactic migration and cellular invasion in SK-OV3 human ovarian cancer cells: involvement of pertussis toxin-sensitive G-protein coupled receptor. FEBS Lett 581 23 (2007) 4411-4416
75. Baker D., Pryce G., Davies W.L., and Hiley C.R. In silico patent searching reveals a new cannabinoid receptor. Trends Pharmacol Sci 27 1 (2006) 1-4
76. Johns D.G., Behm D.J., Walker D.J., et al. The novel endocannabinoid receptor GPR55 is activated by atypical cannabinoids but does not mediate their vasodilator effects. Br J Pharmacol 152 5 (2007) 825-831
77. Ryberg E., Larsson N., Sjogren S., et al. The orphan receptor GPR55 is a novel cannabinoid receptor. Br J Pharmacol 152 7 (2007) 1092-1101
78. Oka S., Nakajima K., Yamashita A., Kishimoto S., and Sugiura T. Identification of GPR55 as a lysophosphatidylinositol receptor. Biochem Biophys Res Commun 362 4 (2007) 928-934
79. Oka S., Toshida T., Maruyama K., Nakajima K., Yamashita A., and Sugiura T. 2-Arachidonoyl-sn-glycero-3-phosphoinositol: a possible natural ligand for GPR55. J Biochem 145 1 (2009) 13-20
80. 1-receptor-triggered repression. J Cell Sci 121 Pt 10 (2008) 1704-1717
81. Staton P.C., Hatcher J.P., Walker D.J., et al. The putative cannabinoid receptor GPR55 plays a role in mechanical hyperalgesia associated with inflammatory and neuropathic pain. Pain 139 1 (2008) 225-236
82. Lauckner J.E., Jensen J.B., Chen H.Y., Lu H.C., Hille B., and Mackie K. GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current. Proc Natl Acad Sci USA 105 7 (2008) 2699-2704
83. 2+ signaling and NFAT activation. Faseb J 23 1 (2009) 183-193
84. Godlewski G., Offertaler L., Wagner J.A., and Kunos G. Receptors for acyethanolamides - GPR55 and GPR119. Prostaglandins Other Lipid Mediat (2009) 88 in press
85. Soga T., Ohishi T., Matsui T., et al. Lysophosphatidylcholine enhances glucose-dependent insulin secretion via an orphan G-protein-coupled receptor. Biochem Biophys Res Commun 326 4 (2005) 744-751
86. Overton H.A., Babbs A.J., Doel S.M., et al. Deorphanization of a G protein-coupled receptor for oleoylethanolamide and its use in the discovery of small-molecule hypophagic agents. Cell Metab 3 3 (2006) 167-175
87. Overton H.A., Fyfe M.C., and Reynet C. GPR119, a novel G protein-coupled receptor target for the treatment of type 2 diabetes and obesity. Br J Pharmacol 153 Suppl 1 (2008) S76-81
88. Brown A.J. Novel cannabinoid receptors. Br J Pharmacol 152 5 (2007) 567-575
89. i/o. J Biol Chem 277 35 (2002) 31459-31465
90. Jones C.E., Holden S., Tenaillon L., et al. Expression and characterization of a 5-oxo-6E, 8Z, 11Z, 14Z-eicosatetraenoic acid receptor highly expressed on human eosinophils and neutrophils. Mol Pharmacol 63 3 (2003) 471-477
91. i/o-protein-coupled receptor, mediates 5-oxo-eicosatetraenoic acid-induced chemotaxis. Biochem Biophys Res Commun 334 4 (2005) 987-995
92. 12/13. J Biochem 139 3 (2006) 543-549
93. Brink C., Dahlen S.E., Drazen J., et al. International Union of Pharmacology XLIV. Nomenclature for the oxoeicosanoid receptor. Pharmacol Rev 56 1 (2004) 149-157
94. Patel P., Cossette C., Anumolu J.R., et al. Structural requirements for activation of the 5-oxo-6E, 8Z, 11Z, 14Z-eicosatetraenoic acid (5-oxo-ETE) receptor: identification of a mead acid metabolite with potent agonist activity. J Pharmacol Exp Ther 325 2 (2008) 698-707
95. Powell W.S. 5-oxo-ETE as a ligand of TG1019. Prostaglandins Other Lipid Mediat (2009) 88 in press
96. Watanabe M., Houten S.M., Mataki C., et al. Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation. Nature 439 7075 (2006) 484-489
97. Thomas C., Pellicciari R., Pruzanski M., Auwerx J., and Schoonjans K. Targeting bile-acid signalling for metabolic diseases. Nat Rev Drug Discov 7 8 (2008) 678-693
98. Maruyama T., Tanaka K., Suzuki J., et al. Targeted disruption of G protein-coupled bile acid receptor 1 (Gpbar1/M-Bar) in mice. J Endocrinol 191 1 (2006) 197-205
99. Vassileva G., Golovko A., Markowitz L., et al. Targeted deletion of Gpbar1 protects mice from cholesterol gallstone formation. Biochem J 398 3 (2006) 423-430
100. Prossnitz E.R. GPCR for estrogen: GPR30. Prostaglandins Other Lipid Mediat (2009) 88 in press
101. Serhan C.N., Chiang N., and Van Dyke T.E. Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol 8 5 (2008) 349-361
102. Serhan C.N., Hong S., Gronert K., et al. Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals. J Exp Med 196 8 (2002) 1025-1037
103. Feltenmark S., Gautam N., Brunnstrom A., et al. Eoxins are proinflammatory arachidonic acid metabolites produced via the 15-lipoxygenase-1 pathway in human eosinophils and mast cells. Proc Natl Acad Sci USA 105 2 (2008) 680-685
104. Seki H., Tani Y., and Arita M. Omega-3 PUFA derived anti-inflammatory lipid mediator resolving E1. Prostaglandins Other Lipid Mediat (2009) 88 in press
105. Claesson H.E. On the biosynthesis and biological role of eoxins and 15-lipoxygenase-1 in airway inflammation and Hodgkin lymphoma. Prostaglandins Other Lipid Mediat 89 (2009) 120-125
106. Rimmerman N., Bradshaw H.B., Hughes H.V., et al. N-palmitoyl glycine, a novel endogenous lipid that acts as a modulator of calcium influx and nitric oxide production in sensory neurons. Mol Pharmacol 74 1 (2008) 213-224
107. Burstein S.H., Adams J.K., Bradshaw H.B., et al. Potential anti-inflammatory actions of the elmiric (lipoamino) acids. Bioorg Med Chem 15 10 (2007) 3345-3355
108. Tan B., Bradshaw H.B., Rimmerman N., et al. Targeted lipidomics: discovery of new fatty acyl amides. Aaps J 8 3 (2006) E461-E465
109. Bradshaw H.B., Lee S.H., and McHugh D. Orphan endogenous lipids and orphan GPCRs: a good match. Prostaglandins Other Lipid Mediat 89 (2009) 131-134
110. Nelson D.L., and Cox M.M. Lehninger principles of biochemistry. 4th ed. (2005), W.H. Freeman and Company, New York
111. Kappos L., Antel J., Comi G., et al. Oral fingolimod (FTY720) for relapsing multiple sclerosis. N Engl J Med 355 11 (2006) 1124-1140
112. Horga A., and Montalban X. FTY720 (fingolimod) for relapsing multiple sclerosis. Expert Rev Neurother 8 5 (2008) 699-714